Search results
Oligonucleotides in the spotlight as GSK snaps up RNA startup for up to $50 million
BioPharma-Reporter· 6 days agoGSK is already developing its own oligonucleotide programs, including bepirovirsen, a phase 3-stage ...
GSK and Ochre Bio link to explore liver disease drivers
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe goal is to prioritise and speed up the development of new treatments for liver conditions. Both...
Arizona Legislature working on $17.2B spending plan works late Friday, resuming efforts today
Today's News-Herald· 2 days agoState lawmakers gave up enacting a new state budget late Friday, hoping to start over again Saturday morning. House Speaker Ben Toma told Capitol Media Services the votes ...
OSHA Issues CSHO Recordkeeping Guidance on Certain Musculoskeletal Treatments During Working Hours
The National Law Review· 2 days agoOSHA regulations provide an exclusive list of treatments that can be administered without being...
Gavi launches vaccine programs for Ebola, meningitis, rabies, and hepatitis B
Center for Infectious Disease Research and Policy· 3 days agoGavi's expanded vaccine portfolio fits its goal of ensuring that lower-income countries have access to key vaccines as soon as possible.
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral...
Digital Journal· 6 days agoA First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More SHELTON ...
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com
Investing.com· 6 days agoThe study, which involved healthy volunteers and patients with a history of liver cirrhosis, was...
We must remember the heroes of the AIDS epidemic, not just the trauma
Las Vegas Sun· 22 hours agoBobbi Campbell in a scene from David Weissman’s film “We Were Here,” a documentary about the height...
Walgreens and KFF’s Greater Than HIV Join with Community Partners to Offer Free HIV and STD Testing...
Morningstar· 6 days agoWalgreens and Greater Than HIV, a public information initiative of KFF, are teaming up with health departments and community organizations to offer free rapid HIV testing ...
Vir Biotechnology (NASDAQ:VIR) Trading Down 5.5%
ETF DAILY NEWS· 24 hours agoShares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) dropped 5.5% during trading on Friday . Approximately 272,073 shares traded hands during mid-day trading, a
